Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- Advertising (6)
- Labelling and packaging (6)
- Legislation (6)
- Assessed listed medicines (5)
- Listed medicines (5)
- Non-prescription medicines (5)
- Therapeutic goods regulation (3)
- Prescription medicines (2)
- COVID-19 (1)
- In Vitro Diagnostic medical devices (IVDs) (1)
- Manufacturing (1)
- Scheduling (national classification system) (1)
- Sunscreens (1)
Search
22 result(s) found, displaying 1 to 22
-
Therapeutic Goods (Biologicals-Application Form for Priority Applicant Determinations) Approval 2022
NoticesApproval of the Therapeutic Goods (Biologicals—Application Form for Priority Applicant Determinations) -
NoticesListed medicine ingredients and requirements are updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 5) 2022.
-
NoticesArrangement under subsection 7C(1) of the Therapeutic Goods Act 1989 for use of computer programs to make decisions under sections 61(3)(a), 61(5AA), and 61(5AB) of the Act
-
NoticesThe TGA has issued a direction notice to MDNE Enterprises Pty Ltd to cease promoting the use and supply of nicotine vaping products to the Australian public.
-
NoticesUpdate to the manufacturing principles for medicinal products
-
NoticesThis labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard.
-
NoticesThis labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard.
-
NoticesThis labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard.
-
NoticesThe TGA has issued a direction notice to 13 Vape Pty Ltd and an executive officer to cease promoting the use and supply of nicotine vaping products to Australian consumers.
-
NoticesListed medicine ingredients and requirements are updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 4) 2022.
-
NoticesThis labelling exemption is granted under section 1.1(3) of Part 2 of the current Poisons Standard.
-
NoticesDirection Notice issued to cease advertisement of prescription and illegal products
-
NoticesThis Order revokes Therapeutic Goods (Groups) Order No. 1 of 1992.
-
NoticesThis Order may be cited as Therapeutic Goods (Groups) Order No. 1 of 1992.
-
NoticesThis Order revokes Therapeutic Goods (Groups) Order No. 1 of 1991.
-
NoticesListed medicine ingredients and requirements are updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2022.
-
NoticesA new Therapeutic Goods Determination for listed medicine ingredients commences on 1 March 2022.
-
NoticesThis labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard.
-
NoticesA new Therapeutic Goods Determination for listed medicine ingredients commenced on 18 January 2022.
-
NoticesThis instrument is the Therapeutic Goods (Poisons Standard) (COVID-19 Treatment—Merck Sharp and Dohme) (Molnupiravir) Labelling Exemption 2022.
-
NoticesThis labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard.
-
NoticesTherapeutic Goods Order No. 1 of 2010.